We are live on ! Find out more
ENSC icon

Ensysce Biosciences
ENSC

17 hedge funds and large institutions have $834K invested in Ensysce Biosciences in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

109% more capital invested

Capital invested by funds: $399K → $834K (+$435K)

55% more funds holding

Funds holding: 11 → 17 (+6)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

4.29% more ownership

Funds ownership: 7.56% → 11.85% (+4.3%)

Holders
17
Holders Change
+6
Holders Change %
+54.55%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
+$149K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$79K
3
Renaissance Technologies
Renaissance Technologies
New York
+$33.5K
4
Citadel Advisors
Citadel Advisors
Florida
+$31.2K
5
VF
Virtu Financial
New York
+$30.6K

Top Sellers

Rank Fund Capital Flow
1
SS
SBI Securities
Japan
-$4.13K
2
Morgan Stanley
Morgan Stanley
New York
-$843
3
Raymond James Financial
Raymond James Financial
Florida
-$210
4
TRCT
Tower Research Capital (TRC)
New York
-$45
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$205K – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$177K – – –
DS
3
DRW Securities
Illinois
$164K +$149K +69,145 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$87K +$79K +36,708 New
Renaissance Technologies
5
Renaissance Technologies
New York
$36.9K +$33.5K +15,574 New
Citadel Advisors
6
Citadel Advisors
Florida
$34.4K +$31.2K +14,518 New
VF
7
Virtu Financial
New York
$34K +$30.6K +14,222 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$30.9K +$6.17K +2,869 +28%
XT
9
XTX Topco
Cayman Islands
$26K +$23.6K +10,957 New
TIAM2
10
Tru Independence Asset Management 2
Oregon
$24.9K +$22.6K +10,500 New
FIA
11
FNY Investment Advisers
New York
$7K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$3.19K -$45 -21 -2%
UBS Group
13
UBS Group
Switzerland
$1.9K +$959 +446 +126%
SS
14
SBI Securities
Japan
$991 -$4.13K -1,918 -82%
BlackRock
15
BlackRock
New York
$154 – – –
Bank of America
16
Bank of America
North Carolina
$57 +$11 +5 +26%
AssetMark Inc
17
AssetMark Inc
California
$31 +$28 +13 New
Morgan Stanley
18
Morgan Stanley
New York
– -$843 -378 Closed
Raymond James Financial
19
Raymond James Financial
Florida
– -$210 -94 Closed

ENSC Hedge Fund Activity: Q3 2025 in Review

17 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q3 2025, worth a combined $834K — up 109% from $399K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ENSC positions and 2 closed out — a net gain of 6 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was DRW Securities, opening a new position worth an estimated $149K. The largest seller was SBI Securities, cutting an estimated $4.13K.

  • 17 institutional investors held Ensysce Biosciences (ENSC) as of Q3 2025, up from 11 in Q2 2025.
  • Funds reported $834K of Ensysce Biosciences stock for Q3 2025, up 109% quarter-over-quarter.
  • 8 funds opened new Ensysce Biosciences positions in Q3 2025 and 2 closed out, a net change of +6 holders.
  • The largest Ensysce Biosciences buyer in Q3 2025 was DRW Securities, an estimated $149K added.
  • The largest Ensysce Biosciences seller in Q3 2025 was SBI Securities, an estimated $4.13K sold.

Based on aggregated 13F filings for Q3 2025.